Business Wire

FL-KINAXIS

18.6.2024 17:01:27 CEST | Business Wire | Press release

Share
Introducing Maestro: The First AI-Infused Supply Chain Orchestration Platform from Kinaxis

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today introduced the Kinaxis Maestro™ platform, the only AI-infused supply chain orchestration platform with a powerful combination of proprietary computational technologies and techniques that provides full transparency and agility across the entire supply chain — from multi-year strategic planning to last-mile delivery. An evolution of the company’s flagship platform, RapidResponse, Maestro incorporates new, modern AI technologies to help teams move faster and smarter to master the complexities of today’s modern supply chains.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240618998841/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Kinaxis announced its AI-infused orchestration platform, Maestro, at global supply chain conference Kinexions in Miami, FL. (Graphic: Business Wire)

The Maestro platform comprises three layers: a supply chain data fabric connecting internal and external data sources into a single source of truth, an always-on intelligence engine that delivers real-time insights, predictions and adaptive solutions, and a seamless user interface, enabling business leaders to make faster and more valuable decisions than ever before, from anywhere and from any device. For example, in response to skyrocketing demand of a new EV following a high-profile celebrity endorsement, an automaker concerned about component shortages might ask ‘How do I prevent a stockout?’. Without missing a beat, Maestro’s generative AI-powered intelligent assistant will provide guidance based on supply chain best practices to ensure disruptions are absorbed and managed in real-time.

"It’s a challenging time to be a business leader in supply chain. Managing the complexities of global and regional supply chains, balancing agility, cost reduction, and sustainability, and handling a steady stream of geopolitical, economic, and environmental disruptions amid a data explosion,” said Andrew Bell, chief product officer at Kinaxis. “Yet, with the right technologies, there's unprecedented potential to resolve this complexity and master uncertainty. Maestro provides total supply chain transparency, aligns advanced technology with specific challenges, and integrates diverse data—from social media sentiment to government regulations—bringing clarity to chaos so business leaders can sleep soundly at night."

National Instruments took part in the beta phase of Maestro’s generative AI capabilities and Ed Scott, chief program manager said, “From the moment our team deployed Maestro’s intelligent assistant, it was clear it would be a gamechanger. We’ve been able to significantly cut down on the amount of time it takes for users to maximize the value of the platform and we are eager to build on these initial successes as Kinaxis continues to roll out the full breadth of its AI capabilities.”

What makes Maestro different:

  • Seamless synchronization. Unmatched agilityGain a comprehensive, always-on digital view of your supply chain, ensuring continuous synchronization of data, people, and processes for unmatched agility.
  • Be ready. Whatever happensPredict future scenarios with smart modeling and make informed decisions quickly to confidently navigate uncertainties and drive success.
  • Strike the perfect balance of accuracy, efficiency, and speed – Fuse machine learning, heuristics and optimization for unparalleled problem-solving, keeping your supply chain at the cutting edge.
  • Take your productivity to the next level – Automate routine tasks with AI and predictive algorithms, allowing you to focus on strategic priorities and boost productivity.
  • Empower your people to do more with more – Empower your teams with an intuitive tool that simplifies complex tasks and enhances efficiency, enabling greater satisfaction and achievement.
  • No data wrangling required – Achieve faster time-to-value by easily ingesting data from various sources without the need for schema definition; just drag, drop, and go.

Global market intelligence firm IDC previewed Maestro prior to launch and Eric Thompson, IDC Worldwide Supply Chain Planning Research Director, noted, “IDC has been discussing end-to-end supply chain integration, and Kinaxis is making moves forward with Maestro. The platform’s progress in combining end-to-end concurrency with smart, user-friendly AI, is a promising step in supply chain orchestration.”

From building the first in-memory material requirements planning (MRP) engine in the 1980s to adopting a SaaS model years before its peers and launching the first cloud-friendly planning platform in the 2000s, Kinaxis has been at the forefront of every major technological innovation within the supply chain industry for the past four decades. The company has consistently prioritized designing products to meet the evolving needs of its customers, focusing on pillars of connectivity, intelligence, adaptability, and user-friendliness. In the previous five years alone, the company’s patent portfolio has grown by more than 500%, with over half of those patents awarded for AI and ML-based innovations.

Celebrating its 40th anniversary in 2024, Kinaxis helps companies that supply the agricultural industry with 40% of the world’s tractors, that keep more than 110 billion teeth clean each year, and that ensure more than 35 million pets are fed nutritious meals each year.

About Kinaxis

Kinaxis is a global leader in modern supply chain orchestration. We serve supply chains and the people who manage them in service of humanity. Our software is trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. We combine our patented concurrency technique with a human-centered approach to AI to empower businesses of all sizes to manage their end-to-end supply chain network, from multi-year strategic planning through down-to-the-second execution and last-mile delivery. For more news and information, please visit kinaxis.com or follow us on LinkedIn.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240618998841/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release

Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around

Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release

Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye